Iron deficiency without anemia: Where are we in 2012?;Carence en fer sans aneḿie: Où en est-on en 2012?

Revue Medicale Suisse

Volumn 8, Issue 364, 2012, Pages 2277-2281

  Favrat, B ^a   Waldvogel Abramowski, S ^c   Vaucher, P ^d   Cornuz, J ^b   Tissot, J D ^c  

^a Dèpartement de mèdecine et santè communautaire   (Switzerland)

^b POLICLINIQUE MÉDICALE UNIVERSITAIRE   (Switzerland)

^c Service Regional Vaudois de Transfusion Sanguine   (Switzerland)

^d UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

IRON; IRON DERIVATIVE;

ANEMIA; DRUG FORMULATION; HUMAN; IRON DEFICIENCY; REVIEW; ARTICLE; DRUG DESIGN; INTRAVENOUS DRUG ADMINISTRATION; IRON DEFICIENCY ANEMIA;

ANEMIA, IRON-DEFICIENCY; DRUG DESIGN; HUMANS; INFUSIONS, INTRAVENOUS; IRON; IRON COMPOUNDS;

EID: 84871914476     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Beutler E, Larsh SE, Gurney CW. Iron therapy in chronically fatigued, nonanemic women : A double-blind study. Ann Intern Med 1960;52:378-94.
2. Verdon F, Burnand B, Stubi CL, et al. Iron supplementation for unexplained fatigue in non-anaemic women : Double blind randomised placebo controlled trial. BMJ 2003;326:1124.
3. Guyatt GH, Oxman AD, Ali M, et al. Laboratory diagnosis of iron-deficiency anemia : An overview. J Gen Intern Med 1992;7:145-53.
4. Vaucher P, Druais PL, Waldvogel S, Favrat B. Effect of iron supplementation on fatigue in nonanemic menstruating women with low ferritin : A randomized controlled trial. CMAJ 2012;184:1247-54.
5. Krayenbuehl PA, Battegay E, Breymann C, Furrer J, Schulthess G. Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration. Blood 2011;118:3222-7.
6. Favrat B, Balck K, Gasche C, et al. One 1000 mg iron dose of ferric carboxymaltose improved fatigue in iron-deficient, non-anaemic women in the randomised placebo-controlled study PREFER. BJOG 2012;119:232-3.
7. Schleiffenbaum BE, Schaer DJ, Burki D, et al. Unexpected high prevalence of metabolic disorders and chronic disease among young male draftees - the Swiss Army XXI experience. Swiss Med Wkly 2006;136:175-84.
8. Cable RG, Glynn SA, Kiss JE, et al. Iron deficiency in blood donors : Analysis of enrollment data from the REDS-II Donor Iron Status Evaluation (RISE) study. Transfusion 2011;51:511-22.
9. Bruner AB, Joffe A, Duggan AK, Casella JF, Brandt J. Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girls. Lancet 1996;348:992-6. (Pubitemid 26340755)
10. Murray-Kolb LE, Beard JL. Iron treatment normalizes cognitive functioning in young women. Am J Clin Nutr 2007;85:778-87. (Pubitemid 46393510)
11. Brownlie T, Utermohlen V, Hinton PS, Giordano C, Haas JD. Marginal iron deficiency without anemia impairs aerobic adaptation among previously untrained women. Am J Clin Nutr 2002;75:734-42. (Pubitemid 34256352)
12. Hinton PS, Sinclair LM. Iron supplementation maintains ventilatory threshold and improves energetic efficiency in iron-deficient nonanemic athletes. Eur J Clin Nutr 2007;61:30-9. (Pubitemid 44921113)
13. Brutsaert TD, Hernandez-Cordero S, Rivera J, et al. Iron supplementation improves progressive fatigue resistance during dynamic knee extensor exercise in iron-depleted, nonanemic women. Am J Clin Nutr 2003;77:441-8. (Pubitemid 36133388)
14. Waldvogel S, Pedrazzini B, Vaucher P, et al. Clinical evaluation of iron treatment efficiency among non-anemic but iron-deficient female blood donors : A randomized controlled trial. BMC Med 2012;10:8.
15. Stefansson H, Rye DB, Hicks A, et al. A genetic risk factor for periodic limb movements in sleep. N Engl J Med 2007;357:639-47. (Pubitemid 47267233)
16. Ulfberg J, Nystrom B. Restless legs syndrome in blood donors. Sleep Med 2004;5:115-8. (Pubitemid 38351821)
17. Trotti LM, Bhadriraju S, Becker LA. Iron for restless legs syndrome. Cochrane Database Syst Rev 2012;5:CD007834.
18. Allen RP, Adler CH, Du W, et al. Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS : A multi-centred, placebo-controlled preliminary clinical trial. Sleep Med 2011;12:906-13.
19. Silber MH, Ehrenberg BL, Allen RP, et al. An algorithm for the management of restless legs syndrome. Mayo Clin Proc 2004;79:916-22. (Pubitemid 38879959)
20. Sun ER, Chen CA, Ho G, Earley CJ, Allen RP. Iron and the restless legs syndrome. Sleep 1998;21:371-7. (Pubitemid 128470320)
21. Trost LB, Bergfeld WF, Calogeras E. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. J Am Acad Dermatol 2006;54:824-44.
22. Elston DM. Commentary : Iron deficiency and hair loss : Problems with measurement of iron. J Am Acad Dermatol 2010;63:1077-82.
23. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005;352:1011-23.
24. **Celi J, Samii K, Perrier A, Reny JL. Iron-deficient anemia, anemia of chronic disease or mixed anemia : How to determine the diagnosis ? Rev Med Suisse 2011;7:2020-3.
25. Sasu BJ, Cooke KS, Arvedson TL, et al. Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia. Blood 2010;115:3616-24.
26. Anker SD, Comin Colet J, Filippatos G, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 2009;361:2436-48.
27. **Arlet JB, Pouchot J, Lasocki S, Beaumont C, Hermine O. Iron therapy : Indications, limitations and modality. Rev Med Interne 2012; epub ahead of print.